In the middle stages, TGF-β, matrix metalloproteinases, vasoactive molecules, and reactive oxygen species act as inducers of EMT, and this progressive process ends in tubulointerstitial fibrosis and glomerulosclerosis [41,42]. The gene discussed is TGFB1; the disease is glomerulosclerosis.